Olga Yuryevna Shpichko

Rusnano OJSC operates as an investment company focusing on nanotechnology. Its activities include building nanotechnology infrastructure, which includes the nanotechnology centers of excellence, business incubators and early stage investment funds; It also provides scientific and educational programs. The company was founded on September 19, 2007 and is headquartered in Moscow, Russian Federation.

Rusnano Projects is a private equity and venture capital operating division of the State-owned Rusnano OJSC. The firm was founded in 2007 and is headquartered in Moscow, Russia.

NTpharma LLC develops nanotechnology-based flu vaccines and immune activators. It employs non-replicating genetically modified viruses carrying genes for target proteins to activate the immune system. The company was founded in 2010 and is headquartered in Moscow, Russia.

Mitotech LLC develops medical nanotechnology solutions. The firm's pipeline has a number of drug candidates based on mitochondria-addressed antioxidant. Its specialties include nanobiotechnology, drug development, research and development in biology and medicine. The company was founded by Maxim Skulachev and John W. Elling in 2009 and is headquartered in Moscow, Russia.

SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation.

Trackpore Technology CJSC provides medical equipment for membrane plasmapheresis. It offers cycle of production from development to manufacture of equipment and consumables for procedures of membrane plasmapheresis and cascade plasma filtration. The company was founded in 1998 and is headquartered in Moscow, Russia.

Nanoderm-Profi OOO develops and manufactures anti-aging cosmetics. The firm develops and implements nanotechnologies in the field of dermatology and cosmetology and produces cosmetics under the brand NanoDerm. The company was founded in 2011 and is headquartered in Moscow, Russia.

RusnanoMedInvest (RMI) is a subsidiary of RUSNANO, a 100 percent Russian state-owned company whose mission is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit. RMI was founded in 2012 headquartered in Russian. The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia.